ASP Isotopes Inc (NASDAQ:ASPI) shares are trading significantly higher on Monday. The company issued a business development update detailing its biggest silicon-28 supply deal, as well as a strategic purchase in the United States.
The silicon-28 shipments are scheduled for the first quarter of 2026, and the radiopharmacy deal is expected to be accretive to 2026 revenues, EBITDA, and EPS.
ASP Isotopes shares are surging Friday morning. The company on Thursday provided several positive updates on its isotope enrichment facilities in Pretoria, South Africa.
ASPI shares surged on a $22 million TerraPower loan and critical uranium supply agreements. Trump's expected nuclear energy policy also fueled broader sector enthusiasm.
ASP Isotopes Inc. (NASDAQ: ASPI) shares are trading higher Wednesday afternoon after the company posted year-over-year growth in its first-quarter 2025 financial results and received a favorable analyst update.
U.S. stock futures were slightly lower on Tuesday after ending largely flat on Monday. Futures of major benchmark indices were trading lower in premarket.
Under the agreement terms, Terrpower would provide ASP with a multiple-advance term loan to partially finance a proposed new uranium enrichment in South Africa.
